Literature DB >> 30352735

Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration.

Wei Seong Toh1, Bin Zhang2, Ruenn Chai Lai2, Sai Kiang Lim3.   

Abstract

Mesenchymal stromal cell (MSC) therapies have demonstrated therapeutic efficacy in a wide-ranging array of tissue injury and disease indications. An important aspect of MSC-mediated therapeutic activities is immune modulation. Consistent with the concentration of MSC therapeutic potency in its secretion, a significant proportion of MSC immune potency resides in the small extracellular vesicles (sEVs) secreted by MSCs. These sEVs, which also include exosomes, carry a large cargo enriched in proteins with potent immunomodulatory activities. They have been reported to exert potent effects on humoral and cellular components of the immune system in vitro and in vivo, and may have the potential to support the diametrically opposite pro- and anti-inflammatory functions necessary for tissue repair and regeneration following injury. Following injury, pro-inflammatory activities are necessary to neutralize injury and remove dead or injured tissue, while anti-inflammatory activities to facilitate migration and proliferation of reparative cell types and to increase vascularization and nutrient supply are necessary to repair and regenerate new tissue. Therefore, a critical immunomodulatory requisite of MSC sEVs in tissue regeneration is the capacity to support the appropriate immune activities at the appropriate time. Here, we review how some of the immune regulatory targets of MSC sEVs could support the dynamic immunomodulatory activities during tissue repair and regeneration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  exosome; extracellular vesicles; immunomodulation; mesenchymal stromal cell; proteome; tissue regeneration

Mesh:

Year:  2018        PMID: 30352735     DOI: 10.1016/j.jcyt.2018.09.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  21 in total

1.  Mesenchymal Stem Cell-derived Extracellular Vesicles for Skin Wound Healing.

Authors:  Soo Kim; Joonghoon Park; Tae Min Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Effects of Hypoxia on RNA Cargo in Extracellular Vesicles from Human Adipose-Derived Stromal/Stem Cells.

Authors:  Benjamin Koch; Alec Geßner; Samira Farmand; Dominik C Fuhrmann; Andreas G Chiocchetti; Ralf Schubert; Patrick C Baer
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

3.  Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p.

Authors:  Qing-Zhao Shi; Hong-Mei Yu; Hong-Mei Chen; Miao Liu; Xue Cheng
Journal:  Clin Exp Med       Date:  2021-03-29       Impact factor: 3.984

Review 4.  Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury.

Authors:  Tianhao Yu; Yingxi Xu; Muhammad Arslan Ahmad; Rabia Javed; Haruo Hagiwara; Xiaohong Tian
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 5.  Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?

Authors:  Xuegang Yuan; Timothy M Logan; Teng Ma
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

6.  The State of Exosomes Research: A Global Visualized Analysis.

Authors:  Bin Wang; Dan Xing; Yuanyuan Zhu; Shengjie Dong; Bin Zhao
Journal:  Biomed Res Int       Date:  2019-04-03       Impact factor: 3.411

7.  Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA.

Authors:  Golnar Shojaati; Irona Khandaker; Martha L Funderburgh; Mary M Mann; Rohan Basu; Donna B Stolz; Moira L Geary; Aurélie Dos Santos; Sophie X Deng; James L Funderburgh
Journal:  Stem Cells Transl Med       Date:  2019-07-10       Impact factor: 6.940

8.  Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines.

Authors:  Samira Ahmadvand Koohsari; Abdorrahim Absalan; Davood Azadi
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

Review 9.  A Role for Exosomes in Craniofacial Tissue Engineering and Regeneration.

Authors:  Lyndon F Cooper; Sriram Ravindran; Chun-Chieh Huang; Miya Kang
Journal:  Front Physiol       Date:  2020-01-14       Impact factor: 4.566

Review 10.  Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.

Authors:  Ashim Gupta; Shivaji Kashte; Manu Gupta; Hugo C Rodriguez; Shraddha Singh Gautam; Sachin Kadam
Journal:  Hum Cell       Date:  2020-08-11       Impact factor: 4.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.